Delivery Order SPE2DB20D3101-SPE2DB24FRSU8

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,343.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a specialty medication, with an ultimate completion date of June 11, 2024. The contract is a firm fixed-price arrangement, and there is no set-aside designation mentioned. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $3,874.14 for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs,...
This federal contract award, valued at $3,767.78, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,472.01 Firm Fixed Price delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of July 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,080.29 delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialized medication used for diabetes management. The contract has a firm fixed price pricing type and a period of performance through November 25, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Victoza 3-Pak 18 mg/3 ml pen 3 ml. The $2,396.16 firm fixed-price delivery order has a completion date of December 13, 2021. Amerisourcebergen is the child company of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp is a $5,843.56 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical for pharmaceutical products. The award includes 4,562,926,377 units of Victoza 3-pak 18 mg/3 ml pens, with a performance period through November 29, 2023. Amerisourcebergen is the prime contractor, and this delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,009.21, is for the delivery of medical products including a specific pharmaceutical product, VICTOZA 3-PAK 18 MG/3 ML PEN 3ML. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of December 14, 2023. The contract does not...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,663.61 delivery order is for the supply of 3-pack Victoza 18 mg/3 ml pens. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of pharmaceutical and medical supplies to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,118.87 firm-fixed-price contract is for the supply of Victoza 3-Pak 18 mg/3 ml pens, with a period of performance through November 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRSU8
    Delivery Order

This federal contract award for $1,323.57 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a delivery order type and firm fixed price pricing, is for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The award has an ultimate completion date of August 21, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 2/27/25, 11:45 AM